NO984651L - Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet - Google Patents

Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet

Info

Publication number
NO984651L
NO984651L NO984651A NO984651A NO984651L NO 984651 L NO984651 L NO 984651L NO 984651 A NO984651 A NO 984651A NO 984651 A NO984651 A NO 984651A NO 984651 L NO984651 L NO 984651L
Authority
NO
Norway
Prior art keywords
manufacture
treatment
nervous system
benzone
drugs
Prior art date
Application number
NO984651A
Other languages
English (en)
Norwegian (no)
Other versions
NO984651D0 (no
Inventor
Xavier Vige
Jusus Benavides
Braham Shroot
Vuronique Taupin
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO984651D0 publication Critical patent/NO984651D0/no
Publication of NO984651L publication Critical patent/NO984651L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO984651A 1996-04-05 1998-10-05 Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet NO984651L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604359A FR2747041B1 (fr) 1996-04-05 1996-04-05 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies
PCT/FR1997/000590 WO1997037648A1 (fr) 1996-04-05 1997-04-02 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des maladies du systeme nerveux

Publications (2)

Publication Number Publication Date
NO984651D0 NO984651D0 (no) 1998-10-05
NO984651L true NO984651L (no) 1998-12-03

Family

ID=9490993

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984651A NO984651L (no) 1996-04-05 1998-10-05 Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet

Country Status (23)

Country Link
US (1) US6043280A (de)
EP (1) EP0900078B1 (de)
JP (1) JP2000512619A (de)
KR (1) KR20000005179A (de)
CN (1) CN1221341A (de)
AT (1) ATE189385T1 (de)
AU (1) AU717704B2 (de)
BR (1) BR9708511A (de)
CA (1) CA2250755A1 (de)
CZ (1) CZ317698A3 (de)
DE (1) DE69701258T2 (de)
ES (1) ES2144857T3 (de)
FR (1) FR2747041B1 (de)
GR (1) GR3033061T3 (de)
HU (1) HUP9902167A3 (de)
NO (1) NO984651L (de)
NZ (1) NZ332158A (de)
PL (1) PL329219A1 (de)
PT (1) PT900078E (de)
RU (1) RU2160098C2 (de)
SK (1) SK133398A3 (de)
WO (1) WO1997037648A1 (de)
ZA (1) ZA972875B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
WO2001034633A2 (en) * 1999-11-12 2001-05-17 Fred Hutchinson Cancer Research Center Methods for treatment of human huntington's disease and methods of screening for active agents
US6914074B2 (en) * 2001-12-13 2005-07-05 Wyeth Substituted phenyl naphthalenes as estrogenic agents
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
NZ542690A (en) * 2003-03-28 2009-04-30 Acadia Pharm Inc Muscarinic M1 receptor agonists for pain management
EP3721880B1 (de) 2010-09-01 2022-02-02 Thomas Jefferson University Zusammensetzungen und verfahren zur muskelreparatur und -regeneration
KR101981930B1 (ko) 2017-08-10 2019-05-27 주식회사 에니텍시스 랜딩 장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5455248A (en) * 1993-09-14 1995-10-03 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний

Also Published As

Publication number Publication date
HUP9902167A3 (en) 2000-07-28
KR20000005179A (ko) 2000-01-25
NO984651D0 (no) 1998-10-05
RU2160098C2 (ru) 2000-12-10
SK133398A3 (en) 1999-12-10
CZ317698A3 (cs) 1999-02-17
FR2747041B1 (fr) 1998-05-22
US6043280A (en) 2000-03-28
ES2144857T3 (es) 2000-06-16
DE69701258D1 (de) 2000-03-09
ATE189385T1 (de) 2000-02-15
EP0900078A1 (de) 1999-03-10
AU717704B2 (en) 2000-03-30
CN1221341A (zh) 1999-06-30
AU2392797A (en) 1997-10-29
ZA972875B (en) 1997-10-31
BR9708511A (pt) 1999-08-03
DE69701258T2 (de) 2000-12-21
WO1997037648A1 (fr) 1997-10-16
GR3033061T3 (en) 2000-08-31
HUP9902167A2 (hu) 2000-04-28
PL329219A1 (en) 1999-03-15
EP0900078B1 (de) 2000-02-02
FR2747041A1 (fr) 1997-10-10
NZ332158A (en) 2000-06-23
PT900078E (pt) 2000-07-31
CA2250755A1 (fr) 1997-10-16
JP2000512619A (ja) 2000-09-26

Similar Documents

Publication Publication Date Title
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
NO995006L (no) Nye forbindelser
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
PT912184E (pt) Utilizacao de um derivado de k-252a para o tratamento de doencas do sietma nervoso central ou periferico e sobre-producao de citoquina
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
EE03771B1 (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
TR199901385T2 (xx) Piperidin t�revleri.
NO973531L (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
DE60023154D1 (de) Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use
DE69923117D1 (de) Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application